Nvidia and Eli Lilly launch $1B AI drug discovery lab to cut development time using AI and robotics.

A low-cost gel restored vision in eight patients with rare blindness-causing eye condition hypotony.

Aktis Oncology raised $318 million in a U.S. IPO, pricing at $18 per share and listing on Nasdaq as AKTS.

FDA removes suicide risk warnings from weight-loss drugs due to insufficient evidence.

OpenAI bought healthcare startup Torch for $100 million to improve AI access to medical data.

Haemonetics buys Vivasure Medical for €100M to expand sutureless vascular closure tech.

25% of Medicare dementia patients still get high-risk brain drugs with no clear reason, study finds.

A spider venom-derived drug, IB409, enters human trials to treat heart attacks and strokes by preventing oxygen-deprivation damage.

Johnson & Johnson to build a $2B biotech plant in Wilson, NC, creating 500 jobs by 2027.

Eli Lilly hit $1 trillion market cap on Jan. 9, 2026, driven by strong earnings, drug success, and strategic moves.